Hostname: page-component-74656f9884-8r8nv Total loading time: 0 Render date: 2026-11-10T11:05:52.582Z Has data issue: false hasContentIssue false

Intake of specific carotenoids and the risk of epithelial ovarian cancer

Published online by Cambridge University Press:  01 July 2007

Min Zhang*
Affiliation:
School of Population Health, the University of Western Australia, 35 Stirling Highway, Crawley, Perth, WA 6009, Australia
C. D'Arcy J. Holman
Affiliation:
School of Population Health, the University of Western Australia, 35 Stirling Highway, Crawley, Perth, WA 6009, Australia
Colin W. Binns
Affiliation:
School of Public Health, Curtin University of Technology, GPO Box U1987, Perth, WA 6845, Australia
*
*Corresponding author: Dr Min Zhang, fax +61 8 6488 1188, email min.zhang@uwa.edu.au
Rights & Permissions [Opens in a new window]

Abstract

There has been considerable interest in the role of carotenoids in the chemoprevention of cancer. However, few studies have examined the association between intake of specific carotenoids and the risk of epithelial ovarian cancer and the results for carotenoids have been inconclusive. To investigate whether the intake of α-carotene, β-carotene, β-cryptoxanthin, lutein and zeaxanthin, and lycopene is inversely associated with ovarian cancer risk, a case–control study was conducted in China during 1999–2000. The cases were 254 patients with histologically confirmed epithelial ovarian cancer and 652 age-matched controls were randomly recruited during the same period. Habitual dietary intake and lifestyle were collected by face-to-face interview using a validated and reliable FFQ. The US Department of Agriculture nutrient composition database was used to calculate the intake of specific carotenoids. Unconditional logistic regression analyses were used to estimate OR and 95 % CI, accounting for age, locality, education, BMI, smoking, tea drinking, parity, oral contraceptive use, hormone replacement therapy, menopausal status, family history of ovarian cancer, physical activity and energy intake. Compared with the highest v. the lowest quartile of intake, the adjusted OR were 0·39 (95 % CI 0·23, 0·66) for α-carotene, 0·51 (95 % CI 0·31, 0·84) for β-carotene, 0·51 (95 % CI 0·31, 0·83) for β-cryptoxanthin, 0·45 (0·27, 0·76) for lutein and zeaxanthin, and 0·33 (95 % CI 0·20, 0·56) for total carotenoids, with statistically significant tests for trend. It is concluded that a higher intake of carotenoids can reduce the risk of epithelial ovarian cancer.

Information

Type
Full Papers
Copyright
Copyright © The Authors 2007
Figure 0

Table 1 Selected characteristics of cancer cases and controls* (Number of subjects and percentages)

Figure 1

Table 2 Daily intake of specific carotenoids in cancer cases and controls (Mean values and standard deviations)

Figure 2

Table 3 Risk of epithelial ovarian cancer for quartile daily intakes of specific carotenoids (Adjusted odds ratios and 95 % confidence intervals)